Letko, Brosseau & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.1M | Sell |
358,019
-12,515
| -3% | -$1.44M | 0.69% | 50 |
|
|
2025
Q4 | $39M | Buy |
370,534
+16,545
| +5% | +$1.55M | 0.64% | 51 |
|
|
2025
Q3 | $29.7M | Buy |
353,989
+6,700
| +2% | +$552K | 0.51% | 56 |
|
|
2025
Q2 | $27.5M | Buy |
347,289
+106,380
| +44% | +$8.46M | 0.53% | 52 |
|
|
2025
Q1 | $21.6M | Buy |
240,909
+5,175
| +2% | +$483K | 0.46% | 55 |
|
|
2024
Q4 | $23.5M | Buy |
235,734
+3,425
| +1% | +$353K | 0.45% | 57 |
|
|
2024
Q3 | $26.4M | Sell |
232,309
-1,930
| -0.8% | -$229K | 0.48% | 57 |
|
|
2024
Q2 | $29M | Sell |
234,239
-25,180
| -10% | -$3.24M | 0.55% | 59 |
|
|
2024
Q1 | $34.2M | Sell |
259,419
-2,030
| -0.8% | -$250K | 0.6% | 56 |
|
|
2023
Q4 | $28.5M | Sell |
261,449
-7,760
| -3% | -$806K | 0.52% | 60 |
|
|
2023
Q3 | $27.7M | Sell |
269,209
-3,090
| -1% | -$333K | 0.54% | 57 |
|
|
2023
Q2 | $31.4M | Sell |
272,299
-17,835
| -6% | -$2.03M | 0.59% | 56 |
|
|
2023
Q1 | $30.9M | Sell |
290,134
-48,575
| -14% | -$5.24M | 0.58% | 58 |
|
|
2022
Q4 | $37.6M | Sell |
338,709
-206,012
| -38% | -$21.1M | 0.68% | 57 |
|
|
2022
Q3 | $46.9M | Sell |
544,721
-9,168
| -2% | -$818K | 0.93% | 41 |
|
|
2022
Q2 | $50.5M | Sell |
553,889
-85,870
| -13% | -$7.61M | 0.89% | 38 |
|
|
2022
Q1 | $52.5M | Sell |
639,759
-11,647
| -2% | -$918K | 0.78% | 47 |
|
|
2021
Q4 | $49.9M | Sell |
651,406
-11,855
| -2% | -$944K | 0.72% | 47 |
|
|
2021
Q3 | $49.8M | Sell |
663,261
-33,425
| -5% | -$2.54M | 0.72% | 45 |
|
|
2021
Q2 | $54.2M | Sell |
696,686
-40,022
| -5% | -$2.98M | 0.72% | 50 |
|
|
2021
Q1 | $54.2M | Sell |
736,708
-19,139
| -3% | -$1.41M | 0.74% | 50 |
|
|
2020
Q4 | $59M | Sell |
755,847
-73,816
| -9% | -$5.65M | 0.81% | 45 |
|
|
2020
Q3 | $65.7M | Sell |
829,663
-84,537
| -9% | -$6.62M | 1.02% | 37 |
|
|
2020
Q2 | $67.5M | Sell |
914,200
-54,548
| -6% | -$4.11M | 1% | 37 |
|
|
2020
Q1 | $71.1M | Sell |
968,748
-1,562
| -0.2% | -$123K | 1.22% | 28 |
|
|
2019
Q4 | $84.2M | Sell |
970,310
-57,173
| -6% | -$4.7M | 0.84% | 37 |
|
|
2019
Q3 | $82.5M | Sell |
1,027,483
-58,227
| -5% | -$4.67M | 0.84% | 35 |
|
|
2019
Q2 | $86.9M | Sell |
1,085,710
-88,053
| -8% | -$6.74M | 0.87% | 35 |
|
|
2019
Q1 | $93.2M | Sell |
1,173,763
-85,938
| -7% | -$6.43M | 0.93% | 34 |
|
|
2018
Q4 | $91.8M | Sell |
1,259,701
-387,983
| -24% | -$27.4M | 1.02% | 34 |
|
|
2018
Q3 | $112M | Sell |
1,647,684
-829,959
| -33% | -$52.9M | 1.04% | 32 |
|
|
2018
Q2 | $144M | Sell |
2,477,643
-38,330
| -2% | -$2.16M | 1.31% | 25 |
|
|
2018
Q1 | $131M | Buy |
2,515,973
+2,688
| +0.1% | +$145K | 1.23% | 31 |
|
|
2017
Q4 | $135M | Sell |
2,513,285
-54,847
| -2% | -$3.04M | 1.18% | 35 |
|
|
2017
Q3 | $157M | Sell |
2,568,132
-9,852
| -0.4% | -$597K | 1.42% | 27 |
|
|
2017
Q2 | $158M | Sell |
2,577,984
-41,188
| -2% | -$2.51M | 1.54% | 24 |
|
|
2017
Q1 | $159M | Sell |
2,619,172
-67,302
| -3% | -$4.08M | 1.49% | 27 |
|
|
2016
Q4 | $151M | Buy |
2,686,474
+158,484
| +6% | +$9.28M | 1.38% | 27 |
|
|
2016
Q3 | $151M | Sell |
2,527,990
-71,735
| -3% | -$4.19M | 1.41% | 30 |
|
|
2016
Q2 | $143M | Buy |
2,599,725
+591,706
| +29% | +$31.5M | 1.36% | 30 |
|
|
2016
Q1 | $101M | Sell |
2,008,019
-44,910
| -2% | -$2.2M | 1% | 38 |
|
|
2015
Q4 | $103M | Buy |
2,052,929
+509,930
| +33% | +$25.7M | 1.07% | 36 |
|
|
2015
Q3 | $72.7M | Buy |
+1,542,999
| New | +$82M | 0.74% | 49 |
|
Other funds holding MRK
VCM
VPM
Letko, Brosseau & Associates's MRK Position: Q1 2026 in Review
Letko, Brosseau & Associates reduced its Merck (MRK) stake by 3.4% in Q1 2026, selling an estimated $1.44M and leaving 358,019 shares worth $43.1M. The position accounts for 0.69% of the portfolio, ranked #50.
Letko, Brosseau & Associates first reported a position in MRK in Q3 2015 and has held it in 43 quarters since. The position peaked at $159M in Q1 2017. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Letko, Brosseau & Associates held 358,019 shares of Merck worth $43.1M as of Q1 2026.
- Letko, Brosseau & Associates sold 12,515 Merck shares in Q1 2026, an estimated $1.44M.
- Merck made up 0.69% of Letko, Brosseau & Associates's portfolio in Q1 2026, its #50 holding.
- Letko, Brosseau & Associates first reported a position in Merck in Q3 2015 and has held it in 43 quarters since.
- Letko, Brosseau & Associates's Merck position peaked at $159M in Q1 2017.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Letko, Brosseau & Associates's 13F filing for Q1 2026, filed 12 May 2026.